Scientists investigate why some cancer blood tests might miss the mark
NCT ID NCT05945290
Summary
This study looked at how the way blood samples are collected, stored, and processed can affect the accuracy of tests that look for tiny pieces of cancer DNA in the blood. Researchers at Mayo Clinic worked with 114 women who had early-stage breast cancer to see if factors like the type of blood tube or shipping delays could make cancer DNA harder to detect. The goal is to improve future blood tests for cancer by making sure samples are handled correctly.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
Conditions
Explore the condition pages connected to this study.